The Frost & Sullivan New Product Innovation Award is given to companies that demonstrate outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. The AIGISRx Antibacterial Envelope is designed to address surgical site infections associated with cardiovascular implantable electronic devices.
“Since TYRX was founded, we have been working diligently to research, develop and commercialize technologies which help reduce surgical site infections and improve patient outcomes,” said Robert White, president and CEO of TYRX. “Our team appreciates Frost & Sullivan’s acknowledgement of our product leadership and innovation.”
Learn more about TYRX.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
